cancer-treatment

Documents about cancer-treatment

• Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study#127610ClinicalTrials.gov
• Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders#148770ClinicalTrials.gov
• Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer#802584ClinicalTrials.gov
• Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial#640570ClinicalTrials.gov
• High prevalence of long-term and late effects in a South African childhood cancer survivor cohort#237320SUNScholar
• Evaluation of zongertinib for the treatment of metastatic non-squamous non-small cell lung cancer with <i>HER2</i> TKD activating mutation#287783Figshare
• Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer#343816ClinicalTrials.gov
• Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)#353417ClinicalTrials.gov
• Data Sheet 9_What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis.pdf#363851Figshare
• Engineering a dual stimuli-responsive platform for post-surgical breast cancer treatment#427107Gestión del Repositorio Documental de la Universidad de Salamanca
• EQUAL TREATMENT, UNEQUAL OUTCOMES: EXAMINING RACIAL, ETHNIC, AND GEOGRAPHIC DISPARITIES IN HEALTH-RELATED QUALITY OF LIFE AMONG BREAST CANCER CLINICAL TRIAL PARTICIPANTS#455927RUcore, Rutgers University Community Repository
• Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)#18627ClinicalTrials.gov
• Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA#123456ClinicalTrials.gov
• Causal estimands and target trials for the effect of lag time to treatment of cancer patients#164866Unpaywall
• A deep learning-driven automated treatment planning framework for cervical cancer patients treated with volumetric modulated arc therapy.#185942NCBI PubMed Central
• Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma#195312ClinicalTrials.gov
• Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer#208465ClinicalTrials.gov
• Health economic evaluation of Mirvetuximab soravtansine for the treatment of FRα-positive, platinum resistant ovarian cancer in Germany.#221049NCBI PubMed Central
• The role of the microbiome in gynecological cancers: implications for diagnosis and treatment#283323Digital Commons @ Michigan Tech
• Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA#303581ClinicalTrials.gov
• Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases#311895HAL (France)
• Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer#353298ClinicalTrials.gov
• Development of Second Malignancies Following Chemotherapy With or Without Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer.#382510NCBI PubMed Central
• A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma#387212ClinicalTrials.gov
• Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer#390931ClinicalTrials.gov
• Digital Mental Health Treatment and Symptoms of Depression and Anxiety in Breast Cancer Survivors: A Randomized Clinical Trial.#392992NCBI PubMed Central
• Cancer-related fatigue during treatment with neoadjuvant and/or adjuvant immune checkpoint inhibitors: a systematic review and meta-analysis.#437127NCBI PubMed Central
• Third-line treatment of biliary tract cancers in a real-life setting#475959HAL (France)
• Conversations in rectal cancer treatment: a qualitative study of multidisciplinary clinician perspective into non-operative management decision-making discussions.#479204NCBI PubMed Central
• A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax#630671Lund University Publications
• The impact of neighborhood socioeconomic deprivation on metastatic pancreatic cancer treatment and survival: An incidence-based, causally-structured observational study#663850bioRxiv / medRxiv
• Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study#668923ClinicalTrials.gov
• Burden of Treatment-Induced Vasomotor Symptoms in Men With Prostate Cancer on Androgen-Deprivation Therapy: A Systematic Literature Review.#685758NCBI PubMed Central
• Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer#805043ClinicalTrials.gov
• A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer#256883ClinicalTrials.gov
• Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Toripalimab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement#127589ClinicalTrials.gov
• Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer#185551IRIS
• Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study#230407ClinicalTrials.gov
• A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment#272339ClinicalTrials.gov
• A germline variant of ring finger protein 43 in an early onset, treatment-resistant metastatic gastric cancer: a case report#428461Repositorio Universidad del Desarrollo
• Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer#481757ClinicalTrials.gov
• Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer#803298ClinicalTrials.gov
• Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer#429747ClinicalTrials.gov
• SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer#287545ClinicalTrials.gov
• Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy#121364ClinicalTrials.gov
• Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial#127569ClinicalTrials.gov
• Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study#143674ClinicalTrials.gov
• Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment#146456ClinicalTrials.gov
• Work Ability in Young Adult Survivors (WAYS WF-10217): Documenting Labor Force Participation, Occupation, and Educational Attainment Following Cancer Treatment.#154238NCBI PubMed Central
• Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC#201595ClinicalTrials.gov